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New Insights Toward Choice of Revascularization*Mandeep Singh, MD, MPHSEE PAGE 985T he incidence of acute kidney injury (AKI)varies widely after coronary revasculariza-tion, likely because of the incorporation of
studies spanning 3 decades, different deﬁnitions
used to deﬁne AKI, and variation in the use of volume
expansion and iso-osmolar contrast media protocols.
Recent widespread adoption of the Acute Kidney
Injury Network classiﬁcation system (Table 1) has pro-
vided us with useful estimates of AKI using standard-
ized deﬁnitions. A recent estimate of the incidence of
AKI after percutaneous coronary intervention (PCI) in
985,737 patients from the contemporary National
Cardiovascular Data Registry was 7.1% (1). There is a
paucity of data on AKI after coronary artery bypass
grafting (CABG) using the Acute Kidney Injury
Network deﬁnition. The incidence of AKI was 19.8%
in a recent study with a small sample size (2).
The etiologies of AKI after PCI are poorly understood
but are believed to be related to contrast-mediated
acute tubular necrosis resulting in medullar hypoxia
or to direct cytotoxic effects of contrast agents.
Tubular injury may be exacerbated with renal vaso-
constriction. The etiology of AKI in patients under-
going CABG, in contrast, includes intraoperative
hypotension, postoperative complications that limit
renal perfusion, atheroemboli, and reperfusion injury.
Regardless of the etiology, the presence of AKI is a
predictor of poor outcomes after coronary revascular-
ization. AKI is associated with increased risk for
myocardial infarction, bleeding, dialysis, and poor
short-term and long-term survival (2–4). Even a small
increase in serum creatinine is associated with very
poor survival (5). Not only does AKI itself lead to*Editorials published in the Journal of the American College of Cardiology
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the contents of this paper to disclose.adverse outcomes, but it is also associated with higher
bleeding rates (Table 2). The predictors of AKI after
revascularization are the acuity and severity of pre-
sentation (acute coronary syndrome or ST-segment
elevation myocardial infarction and cardiogenic
shock), congestive heart failure, pre-existing chronic
kidney disease, contrast medium use, and the pres-
ence of diabetes mellitus (1). Excellent predictive
models are now available to aid clinicians in the
prediction of AKI (6).
Comparative effectiveness research educates phy-
sicians and patients on the risks of PCI and CABG.
Armed with that information, it helps physicians and
patients choose among alternative approaches and
aids in patients’ clinical management. Randomized
clinical trials have traditionally been used to compare
treatment efﬁcacy, but they have limited use in “real-
world” practice because of stringent enrollment
criteria and small sample sizes, limiting the general-
izability of their conclusions. They are less suitable for
examining variations in clinical effectiveness across
patient populations treated in typical practice settings.
Current efforts comparing the effectiveness of
PCI versus CABG in patients with multivessel dis-
ease, from retrospective, observational data, have
advanced our knowledge and will likely help in the
selection of PCI or CABG as a revascularization strat-
egy. Previous attempts clearly deﬁned a survival
advantage of CABG over PCI in subsets with diabetes
mellitus, congestive heart failure, and peripheral
vascular disease, as well as smokers (7,8).The present study illustrates the importance of AKI
after coronary revascularization, which may inﬂuence
the choices made by patients and providers. Chang
et al. (9), in this issue of the Journal, report 2- to 3-fold
higher adjusted risk for AKI in patients undergoing
multivessel revascularization with CABG compared
with PCI. The investigators studied 2 cohorts (Kaiser
TABLE 1 Classiﬁcation/Staging System for Acute Kidney Injury
Stage Serum Creatinine Criteria Urine Output Criteria
1 Increase in serum creatinine of $0.3 mg/dl
($26.4 mmol/l) or increase to $150% to
200% (1.5- to 2-fold) from baseline
<0.5 ml/kg/h for >6 h
2* Increase in serum creatinine to >200% to 300%
(>2- to 3-fold) from baseline
<0.5 ml/kg/h for >12 h
3† Increase in serum creatinine to >300% (>3-fold)
from baseline (or serum creatinine of $4.0 mg/dl
[$354 mmol/l] with an acute increase of
$0.5 mg/dl [44 mmol/l])
<0.3 ml/kg/h for 24 h
or anuria for 12 h
Adapted from the RIFLE (risk, injury, failure, loss, and end-stage kidney disease) criteria. The staging system
proposed is a highly sensitive interim staging system and is based on recent data indicating that a small change in
serum creatinine inﬂuences outcome. Only 1 criterion (creatinine or urine output) has to be fulﬁlled to qualify for
a stage. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve
outcomes in acute kidney injury. Crit Care 2007;11:R31. *A 200% to 300% increase is equivalent to a 2- to 3-fold
increase. †Given wide variation in indications for and timing of initiation of renal replacement therapy, patients
who receive it are considered to have met the criteria for stage 3 irrespective of the stage they are in at the time
of therapy.
TABLE 2 Incidence of Death, Bleeding, and MI Stratiﬁed
by AKIN Stage
AKIN Stage Death (%) Bleeding (%) MI (%)
No AKI 0.5 1.4 2.1
1 6.6 5.4 3.3
2 24.6 11.4 5.9
3 23.4 9.5 5.7
Reprinted from Tsai et al. (1).
AKI ¼ acute kidney injury; AKIN¼ Acute Kidney Injury Network; MI ¼myocardial
infarction.
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996Permanente Northern California and Medicare bene-
ﬁciaries) and found a higher incidence of AKI in the
Kaiser Permanente cohort (20.4%) compared with
older patients (6.2%) enrolled in the Medicare cohort.
The incidence of dialysis at 90 days after the index
procedure was 15% in the Medicare cohort in patients
with underlying chronic kidney disease.
There are signiﬁcant limitations in the present
analyses that must be underscored. First, derivation
from administrative database can lead to ascertain-
ment bias. The incidence of AKI was lower in the
Medicare population than in the younger population
in the Kaiser Permanente Northern California cohort.
Second, the data spanned 13 years. The risk proﬁles of
patients and strategies to prevent and treat AKI have
evolved, such that reporting of secular trends for AKI
would add meaningful information to the present
study. Third, the study’s retrospective nature and its
use of propensity analyses for matching (poor for
Medicare patients) would lead to biased estimatesdue to residual confounding. Fourth, knowledge of
coronary anatomy, its complexity, and the availabil-
ity of SYNTAX (Synergy Between PCI With Taxus and
Cardiac Surgery) score would have provided impor-
tant knowledge to readers. Fifth, in patients under-
going PCI, the incidence of AKI may be lower because
these patients are discharged the day after the pro-
cedure, and increases in serum creatinine may occur
after dismissal.
Notwithstanding these limitations, this study has
signiﬁcantly advanced our knowledge and will help us
in the selection of revascularization. In patients with
multivessel disease, diabetes mellitus, low ejection
fractions, high SYNTAX scores, or peripheral vascular
disease, improved survival with CABG has been
demonstrated (10). However, patients with low SYN-
TAX scores and with baseline chronic kidney disease
can be favorably treated percutaneously. There is an
evolution in our thinking as we strategize the choice of
revascularization for an average patient, taking into
consideration some readily available covariates.
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